On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Viscogel AB's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€736k · 1 project
Projects
1 EU-funded project, newest first. Viscogel AB led 1 of them as coordinator. Each links to the official record.
- VIVACCoordinator
Viscogel - A chitosan based adjuvant for prophylactic and therapeutic vaccination
FP7 (2007 to 2013) · 2010–2012 · Project on CORDIS ↗
€736ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Karolinska InstitutetSweden · 1 shared project
- Norges Teknisk-Naturvitenskapelige Universitet NTNUNorway · 1 shared project
- Region StockholmSweden · 1 shared project
- Hacettepe UniversitesiTürkiye · 1 shared project
- Envigo Crs LimitedUnited Kingdom · 1 shared project
- Inmunotek SLSpain · 1 shared project
- Lytix Biopharma ASNorway · 1 shared project
- Pharma Consulting Group In Uppsala ABSweden · 1 shared project
- Stallergenes SAFrance · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- allergology
- carbohydrates
- immunology
- infectious diseases
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.